47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 25,2 | |||
Gross profit (loss) | -0 | -0 | -0,1 | -267,1 |
EBITDA | 14,9 | |||
Short time liabilities | 10,3 | |||
Income tax | 0 | 0 | -0 | -1126,4 |
Other operating costs | 58 | |||
Equity capital | -0,3 | -0,3 | -0,5 | -39,6 |
Operating profit (EBIT) | 15,2 | |||
Assets | 0,5 | 0,8 | 0,8 | 6,4 |
Net profit (loss) | -0 | -0 | -0,1 | -260,7 |
Cash | 95,1 | |||
Net income from sale | -10,7 | |||
Liabilities and provisions for liabilities | 0,8 | 1,1 | 1,3 | 16,7 |
Working assets | 0,4 | 0,5 | 0,6 | 15,4 |
Other income costs | 10 295,1 | |||
Basic operational activity income | 2,5 | 2,9 | 3,3 | 16 |
Depreciation | -17 | |||
% | % | % | p.p. | |
Profitability of capital | -72,7 | |||
Equity capital to total assets | -63,6 | -44,8 | -58,7 | -13,9 |
Gross profit margin | -2 | -1,3 | -4,1 | -2,8 |
EBITDA Margin | 0,2 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | |||
Current financial liquidity indicator | -0,1 | |||
Net dept to EBITDA | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane